help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-2017
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kornak, U.
Right arrow Articles by de Vernejoul, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kornak, U.
Right arrow Articles by de Vernejoul, M.-C.
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 3 995-1000
Copyright © 2006 by The Endocrine Society

Polymorphisms in the CLCN7 Gene Modulate Bone Density in Postmenopausal Women and in Patients with Autosomal Dominant Osteopetrosis Type II

U. Kornak, A. Ostertag, S. Branger, O. Benichou and M.-C. de Vernejoul

Max Planck Institute for Molecular Genetics and Institute for Medical Genetics (U.K.), Charité University Hospital, D-13353 Berlin, Germany; Institut National de la Santé et de la Recherche Médicale U 606 (A.O., S.B., O.B., M.-C.d.V.) and Fédérationde Rhumatologie (M.-C.d.V.), Hôpital Lariboisière, 75010 Paris, France

Address all correspondence and requests for reprints to: Marie-Christine de Vernejoul, Institut National de la Santé et de la Recherche Médicale U 606, Hôpital Lariboisière, 2, rue Ambroise Paré, 75010 Paris, France. E-mail: uwe.kornak{at}charite.de (U.K.); nezumi{at}netcourrier.fr (S.B.); agnes.ostertag{at}larib.inserm.fr (A.O.); benizeph{at}free.fr (O.B.); christine.devernejoul{at}inserm.lrb.ap-hop-paris.fr (M.-C.d.V.).

Context: Genetic factors are important determinants of bone mineral density (BMD). The fact that mutations in the ClC-7 chloride channel cause autosomal dominant osteopetrosis (ADOII) make the CLCN7 gene an attractive candidate for the regulation of bone density.

Objective: The objective of the study was to investigate the association between polymorphisms in the CLCN7 gene and BMD in postmenopausal women and with clinical variability in ADOII.

Design: This was a genetic association study using five single-nucleotide polymorphisms and a variable number tandem repeat (VNTR) polymorphism in the CLCN7 gene.

Participants: A total of 425 postmenopausal women aged 64 ± 7 yr participated in the study. We also investigated an ADOII family with low penetrance comprising 18 mutation carriers.

Main Outcome Measure(s): In our postmenopausal cohort, individual single-nucleotide polymorphism genotypes and haplotypes were analyzed for association with BMD at the lumbar spine and the femoral neck and with the bone resorption marker deoxypyridinoline (D-Pyr/Crea). The same polymorphisms on the nonmutated CLCN7 allele were investigated for association with the variability of the ADOII phenotype.

Results: Analysis by multiple linear regression revealed a significant association between the ss genotype of the VNTR and higher Z-score values (P = 0.029). The haplotype 4, which comprises the long allele of the VNTR, was found to be significantly associated with lower femoral neck Z-score values (P = 0.011). Furthermore, we found an association of the ss genotype of the VNTR with lower levels of the bone resorption marker D-Pyr/Crea (P = 0.015), whereas haplotype 4 was associated with higher D-Pyr/Crea levels (P = 0.039). In the ADOII family, we could demonstrate that haplotype 3, which contains the s-allele of the VNTR, is associated with a slightly higher probability that mutation carriers develop osteopetrosis (P = 0.029). In both cases the association seems largely to be driven by the VNTR genotype but is further strengthened if surrounding polymorphisms are added to the analysis.

Conclusion: We observed a significant association of CLCN7 polymorphisms with the variance of BMD and bone resorption marker levels in postmenopausal women and with the variability of the ADOII phenotype.




This article has been cited by other articles:


Home page
IBMS BoneKEyHome page
A. Del Fattore, M. Capannolo, and A. Teti
New Mechanisms of Osteopetrosis
IBMS BoneKEy, January 1, 2009; 6(1): 16 - 28.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
S. Ferrari
Single Gene Mutations and Variations Affecting Bone Turnover and Strength: a Selective 2006 Update
IBMS BoneKEy, December 1, 2006; 3(12): 11 - 29.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society